Molecular Basis for Modulation of the p53 Target Selectivity by KLF4

被引:11
|
作者
Brandt, Tobias [1 ,2 ]
Townsley, Fiona M. [1 ]
Teufel, Daniel P. [1 ]
Freund, Stefan M. V. [1 ]
Veprintsev, Dmitry B. [1 ,3 ,4 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
[2] Max Planck Inst Biophys, D-6000 Frankfurt, Germany
[3] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland
[4] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland
来源
PLOS ONE | 2012年 / 7卷 / 10期
基金
英国医学研究理事会;
关键词
TUMOR-SUPPRESSOR P53; INTERACTING PROTEIN KINASE-2; DNA-BINDING SPECIFICITY; C-TERMINAL DOMAIN; TRANSACTIVATION SUBDOMAINS; CORE DOMAIN; COMPLEX; PHOSPHORYLATION; ACTIVATION; RADIATION;
D O I
10.1371/journal.pone.0048252
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The tumour suppressor p53 controls transcription of various genes involved in apoptosis, cell-cycle arrest, DNA repair and metabolism. However, its DNA-recognition specificity is not nearly sufficient to explain binding to specific locations in vivo. Here, we present evidence that KLF4 increases the DNA-binding affinity of p53 through the formation of a loosely arranged ternary complex on DNA. This effect depends on the distance between the response elements of KLF4 and p53. Using nuclear magnetic resonance and fluorescence techniques, we found that the amino-terminal domain of p53 interacts with the KLF4 zinc fingers and mapped the interaction site. The strength of this interaction was increased by phosphorylation of the p53 N-terminus, particularly on residues associated with regulation of cell-cycle arrest genes. Taken together, the cooperative binding of KLF4 and p53 to DNA exemplifies a regulatory mechanism that contributes to p53 target selectivity.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ
    H Solomon
    M Sharon
    V Rotter
    Cell Death & Differentiation, 2014, 21 : 1347 - 1349
  • [32] Structural basis for p53 binding to its nucleosomal target DNA sequence
    Nishimura, Masahiro
    Takizawa, Yoshimasa
    Nozawa, Kayo
    Kurumizaka, Hitoshi
    PNAS NEXUS, 2022, 1 (04):
  • [33] The molecular basis for p53 inhibition of autophagy in porcine fibroblast cells
    Fei, Jimin
    Xu, Anyong
    Zeng, Wen
    Liu, Yukun
    Jiao, Deling
    Zhu, Wanyun
    Xu, Kaixiang
    Li, Honghui
    Wei, Hong-Jiang
    Zhao, Hong-Ye
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (03) : 876 - 886
  • [34] Molecular basis of Pirh2-mediated p53 ubiquitylation
    Sheng, Yi
    Laister, Rob C.
    Lemak, Alexander
    Wu, Bin
    Tai, Elizabeth
    Duan, Shili
    Lukin, Jonathan
    Sunnerhagen, Maria
    Srisailam, Sampath
    Karra, Murthy
    Benchimol, Sam
    Arrowsmith, Cheryl H.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2008, 15 (12) : 1334 - 1342
  • [35] Molecular basis of Pirh2-mediated p53 ubiquitylation
    Yi Sheng
    Rob C Laister
    Alexander Lemak
    Bin Wu
    Elizabeth Tai
    Shili Duan
    Jonathan Lukin
    Maria Sunnerhagen
    Sampath Srisailam
    Murthy Karra
    Sam Benchimol
    Cheryl H Arrowsmith
    Nature Structural & Molecular Biology, 2008, 15 : 1334 - 1342
  • [36] Role of p53 Serine 46 in p53 Target Gene Regulation
    Smeenk, Leonie
    van Heeringen, Simon J.
    Koeppel, Max
    Gilbert, Bianca
    Janssen-Megens, Eva
    Stunnenberg, Hendrik G.
    Lohrum, Marion
    PLOS ONE, 2011, 6 (03):
  • [37] PML is a direct p53 target that modulates p53 effector functions
    de Stanchina, E
    Querido, E
    Narita, M
    Davuluri, RV
    Pandolfi, PP
    Ferbeyre, G
    Lowe, SW
    MOLECULAR CELL, 2004, 13 (04) : 523 - 535
  • [38] P53 is a specific molecular target of ursodeoxycholic acid in regulating apoptosis
    Amaral, Joana D.
    Castro, Rui E.
    Sola, Susana
    Steer, Clifford J.
    Rodrigues, Cecilia Maria P.
    HEPATOLOGY, 2007, 46 (04) : 779A - 779A
  • [39] Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
    Chen, Xiaohua
    Zhang, Taotao
    Su, Wei
    Dou, Zhihui
    Zhao, Dapeng
    Jin, Xiaodong
    Lei, Huiwen
    Wang, Jing
    Xie, Xiaodong
    Cheng, Bo
    Li, Qiang
    Zhang, Hong
    Di, Cuixia
    CELL DEATH & DISEASE, 2022, 13 (11)
  • [40] Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
    Xiaohua Chen
    Taotao Zhang
    Wei Su
    Zhihui Dou
    Dapeng Zhao
    Xiaodong Jin
    Huiwen Lei
    Jing Wang
    Xiaodong Xie
    Bo Cheng
    Qiang Li
    Hong Zhang
    Cuixia Di
    Cell Death & Disease, 13